# Lantheus Holdings, Inc. – Consensus ‘buy’ rating and 75.8% Upside Potential

- Link: https://www.directorstalkinterviews.com/lantheus-holdings-inc.consensus-buy-rating-and-75.8-upside-potential/4121129739
- Published: 2023-10-13T15:30:57+01:00
- Author: Charlotte Edwards

**Lantheus Holdings, Inc.** with ticker code (LNTH) have now 8 confirmed analysts
covering the stock with the consensus suggesting a rating of ‘buy’. The target price
High/Low ranges between 130 and 110 calculating the average target price we see 
$119.63. Now with the previous closing price of $68.03 and the analysts are correct
then we can expect a percentage increase in value of 75.8%. The 50 day moving average
now sits at $67.31 and the 200 moving average now moves to $74.99. The company has
a market capitalization of 4.46B. The stock price for the company is currently 65.23
USD

 The potential market cap would be $7,849,428,979 based on the market consensus.

The company is not paying dividends at this time.

Other points of data to note are a P/E ratio of 138.79, revenue per share of 16.46
and a 8.4% return on assets.

Lantheus Holdings, Inc. is an integrated provider of imaging diagnostics, targeted
therapeutics, and artificial intelligence solutions to find, fight and follow serious
medical conditions. The Company’s products include precision diagnostics, radiopharmaceutical
oncology, and strategic partnerships. Its precision diagnostic products assist healthcare
professionals (HCPs) Find and Follow diseases, with a focus on cardiology. Its radiopharmaceutical
oncology diagnostics and therapeutics help HCPs Find, Fight and Follow cancer. Its
strategic partnerships focus on enabling precision medicine through the use of biomarkers,
digital solutions and pharma services platforms, and also includes the Company’s
license of RELISTOR to Bausch Health Companies, Inc. (Bausch). Its commercial products
are used by oncologists, urologists, nuclear medicine physicians, cardiologists,
sonographers, technologists, radiologists, and internal medicine physicians working
in a variety of clinical settings.

Share on: